electroCore to Participate at Canaccord Genuity MedTech & Diagnostics Forum

Rhea-AI Summary

electroCore, a bioelectronic medicine company (NASDAQ: ECOR), will host virtual one-on-one meetings at the Canaccord Genuity MedTech & Diagnostics Forum on November 18, 2021. The management team aims to discuss its non-invasive vagus nerve stimulation therapy platform designed for treating migraines and cluster headaches, including acute and preventive treatments. Stakeholders interested in a meeting should contact their Canaccord Genuity representative to arrange the details. For more information, visit www.electrocore.com.

ROCKAWAY, NJ, Nov. 11, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will be available for virtual one-on-one meetings at the Canaccord Genuity MedTech & Diagnostics Forum. The conference is taking place virtually November 18, 2021. Details are as follows:

Canaccord Genuity MedTech & Diagnostics Forum:
Date: Thursday, November 18, 2021
Event: One-on-one meetings

Please contact your Canaccord Genuity representative if interested in arranging a one-on-one meeting with electroCore management during the event.

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine, the acute treatment of migraine and episodic cluster headache, the acute and preventive treatment of migraines in adolescents, and paroxysmal hemicrania and hemicrania continua in adults.

For more information, visit www.electrocore.com.

FAQ

When will electroCore have one-on-one meetings?

electroCore will have virtual one-on-one meetings on November 18, 2021.

What is the focus of electroCore's conference participation?

electroCore aims to discuss its bioelectronic medicine therapies at the Canaccord Genuity MedTech & Diagnostics Forum.

How can I arrange a meeting with electroCore management?

To arrange a meeting, please contact your Canaccord Genuity representative.

What conditions does electroCore's therapy address?

The therapy targets migraines, cluster headaches, and other neurological conditions.

Where can I find more information about electroCore?

More information is available at www.electrocore.com.